Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Harvard Business School
Covington
Novartis
Accenture
Cipla
Queensland Health
Moodys
US Department of Justice

Generated: February 24, 2018

DrugPatentWatch Database Preview

METHYCLOTHIAZIDE AND DESERPIDINE Drug Profile

« Back to Dashboard

When do Methyclothiazide And Deserpidine patents expire, and when can generic versions of Methyclothiazide And Deserpidine launch?

Methyclothiazide And Deserpidine is a drug marketed by Watson Labs and is included in two NDAs.

The generic ingredient in METHYCLOTHIAZIDE AND DESERPIDINE is deserpidine; methyclothiazide. There are four drug master file entries for this compound. Additional details are available on the deserpidine; methyclothiazide profile page.
Summary for METHYCLOTHIAZIDE AND DESERPIDINE
Drug patent expirations by year for METHYCLOTHIAZIDE AND DESERPIDINE

US Patents and Regulatory Information for METHYCLOTHIAZIDE AND DESERPIDINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs METHYCLOTHIAZIDE AND DESERPIDINE deserpidine; methyclothiazide TABLET;ORAL 088486-001 Aug 10, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs METHYCLOTHIAZIDE AND DESERPIDINE deserpidine; methyclothiazide TABLET;ORAL 088452-001 Aug 10, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Harvard Business School
McKesson
UBS
Healthtrust
Mallinckrodt
Accenture
AstraZeneca
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot